Abstract-Extremes of sleep duration and obstructive sleep apnea (OSA) are both associated with hypertension. We aimed to explore whether sleep duration modifies the relationship between OSA and prevalent hypertension, using both objective and subjective measures of total sleep duration. A total of 7107 OSA patients and 1118 primary snorers were included in the study. Hypertension was defined based either on direct blood pressure measures or on diagnosis by a physician. Objective sleep duration was derived by polysomnography and subjective sleep duration was self-reported. Logistic regression models were used to estimate the associations between objective/subjective sleep duration and hypertension prevalence in OSA and primary snorers. Compared with primary snorers, OSA combined with objective sleep duration of 5 to 6 hours increased the odds of hypertension by 45% (odds ratio, 1.45; 95% confidence interval, 1.14-1.84), whereas OSA combined with objective sleep duration <5 hours further increased the odds of hypertension by 80% (odds ratio, 1.80; 95% confidence interval, 1.33-2.42). These results were independent of major confounding factors frequently associated with OSA or hypertension. In stratified analysis by sleep duration, risk of hypertension in those with extremely short sleep (<5 hours) was not significantly different between OSA and primary snorers, whereas odds were significant for OSA in the other 4 sleep duration strata (5-6, 6-7, 7-8, and >8 hours). No significance was evident using subjective sleep duration. We conclude that objective short sleep duration is associated with hypertension in OSA patients. Extremely short sleep duration in itself may actually be even more detrimental than OSA in terms of hypertension risk. (Hypertension. 2018;72:610-617.
O bstructive sleep apnea (OSA) is a common disease that affects ≈34% of men and 17% of women aged 30 to 70 years. 1 Cross-sectional and longitudinal studies have consistently identified OSA as an important cause of hypertension. 2, 3 Hypertension is a well-established risk factor for various adverse health outcomes, such as stroke, cardiovascular disease, and mortality, and may mediate the heightened cardiovascular disease risk associated with OSA. 4 Individual variations in sleep duration are influenced by both biological and environmental factors. Recent studies in humans suggest that habitual sleep duration is a stable trait under genetic regulation. 5, 6 Tang et al 7 also found that the rodents under wellhabituated conditions exhibited sleep duration patterns (short, intermediate, or long sleep time) that were consistent within individual animals across days. However, the emerging trend of reduction in sleep duration worldwide during the past decades has led to a growing sleep debt on a population level 8, 9 and uncertain implications for risk of systemic disease.
There is increasing evidence indicating a link between sleep duration and blood pressure (BP). Sleep deprivation in experimental studies may cause significant increases in BP both in normotensive and hypertensive subjects. 10, 11 In addition, epidemiological studies examining the link between sleep duration and hypertension support an independent association between short sleep duration and higher risk for prevalent and incident hypertension. 12, 13 On the contrary, there are studies showing that long sleep may also be associated with increased risk for hypertension. [14] [15] [16] However, the majority of previous studies assessed sleep duration solely based on subjective reports, which are often at variance with objective measures of sleep duration, [17] [18] [19] and those findings may not necessarily be corroborated by objective sleep indicators.
Because both OSA and extremes of sleep duration are individually associated with hypertension, the co-occurrence of inadequate sleep duration in OSA patients may potentially contribute to elevate BP in this population and modify the relationship between OSA and hypertension. 20 To our knowledge, this hypothesis was only explored previously by Priou et al. 21 They found that patients with OSA and short sleep duration, as assessed by polysomnography, had a substantially higher risk of having hypertension compared with those with OSA but normal sleep duration. However, in this aforementioned article short sleep was only defined as a binary variable. The implications of long sleep duration, as well as the role of subjective versus objective sleep duration, remain unknown.
We evaluated a large sample of 8225 patients with and without OSA, and sought to assess (1) whether there is a U-shaped relationship between objective sleep duration, as derived from polysomnography, and risk of hypertension; (2) whether the risk of hypertension differs when using a subjective definition of sleep duration, based on self-report measures; and (3) whether the presence of OSA modulates such risk.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Subjects
This was a cross-sectional study of consecutive patients seen at the Sleep Medicine Center, West China Hospital, China. The study procedure was approved by the University's Institutional Review Board, and informed consent was obtained from each participant.
All participants were Chinese adults (age >18 years), evaluated at the Sleep Center for suspected OSA. All potential research subjects were interviewed with a comprehensive questionnaire to collect information on general health, medication use, and history of sleep complaints.
To qualify for the present study, patients with OSA had to meet an apnea-hypopnea index (AHI) criterion of ≥5 events/h, whereas individuals with an AHI <5 events/h were classified as the primary snoring group. We excluded subjects who had (1) a chronic sleepdisrupting medical condition (eg, pain, heart disease); (2) a current major psychiatric condition (eg, depression); (3) current or recent (within the past 3 months) use of hypnotics, anxiolytics, antidepressants, and any other antipsychotics; and (4) any other comorbid sleep disorder (eg, insomnia, central sleep apnea). Additional information on eligibility criteria is provided in the online-only Data Supplement.
BP Measures
Following standard methods, 22 BP was measured on 2 different occasions: in the evening ≈2 hours before starting polysomnography (ie, 20:00-21:00) and in the morning after the end of the overnight sleep study (ie, 06:00-07:00), when the patient was still recumbent. We used a pneumoelectric microprocessor-controlled instrument (Nissei, DS-1902, Japan) with cuffs of appropriate size. The accuracy of this monitor is reported to be ±3 mm Hg; in addition, internal calibration was performed before each use, and the machine was checked against a mercury sphygmomanometer at least once a year. Recorded BP was the average of 3 consecutive readings during a 5-minute period after at least 10 minutes of rest in the supine position. Hypertension was defined as (1) diastolic BP ≥90 mm Hg or systolic BP ≥140 mm Hg at either evening or morning measurement; (2) use of antihypertensive medication; or (3) physician-diagnosed hypertension as per clinical history. 23 We used the average of evening and morning BP for analysis.
Polysomnography
All subjects underwent 1 night of attended polysomnography recording in a sound-attenuated, light-and temperature-controlled room. All the sleep studies were full-night diagnostic studies. During this evaluation, subjects were allowed to follow their habitual sleep time, with the recording time ranging from 21:00 to 22:00 to 6:00 to 7:00. Sleep data were collected and scored via the Alice 5 Diagnostic Sleep System (Philips Respironics, Bend, OR). All sleep parameters and stages (N1, N2, N3, and rapid eye movement sleep stages) were scored by senior polysomnography technicians according to the American Academy of Sleep Medicine criteria. 24 An apnea was defined as >90% reduction in airflow for at least 10s, whereas hypopnea was defined as ≥50% reduction of airflow for at least 10s associated with ≥3% reduction in Spo 2 . The AHI was calculated as the average number of apneas and hypopneas per hour of sleep. T90% was the percentage of time spent in sleep below 90% oxygen saturation.
Sleep Duration Measures
Subjective sleep duration was assessed during the face-to-face clinical interview as follows: "On average, how many hours of sleep do you usually get per day?". Objective sleep duration was defined as total sleep time (TST) as recorded during overnight polysomnography. Five categories of sleep duration were then derived (>8, 7-8, 6-7, 5-6, and <5 hours).
Statistical Analysis
Data are presented as mean±SD for continuous variables and percent for categorical variables. Comparisons between groups were conducted using independent-sample t tests/ANOVA or Mann-Whitney U tests for normally and skewed distributed continuous variables, respectively, and with the χ 2 test for categorical variables. Logistic regression models were used to assess the independent associations between OSA and subjective and objective sleep duration with hypertension, as well as interaction effects. In a first step, we separately studied the association of hypertension with OSA alone and with short objective and subjective sleep duration alone. In a second step, we determined adjusted odds ratio (OR) and 95% confidence interval (CI) for hypertension considering the joint effect of OSA and objective sleep duration and using primary snorers as a reference group. Then, we calculated the adjusted OR (95% CI) for hypertension associated with OSA in different strata of objective sleep duration. In all models, we sequentially controlled for multiple covariates expected to affect the relationships of interest, including age, sex, body mass index, tobacco, alcohol drinking, coffee use, diabetes mellitus, total time in bed, time spent in N3 sleep stage (%TST), Epworth Sleepiness Scale, T90%, and AHI (or TST, depending on the primary exposure).
To further characterize the association between different objective sleep duration groups and frequency of hypertension and BP values, we conducted an ANOVA. Post hoc Dunnett tests were used to control for type I errors in multiple comparisons. Linear regression models were used to explore the association between BP values and objective and subjective sleep duration in patients with and without OSA, respectively. The covariates we adjusted for included age, sex, body mass index, tobacco, alcohol drinking, coffee use, diabetes mellitus, antihypertensive medications, total time in bed, time spent in N3 sleep stage (%TST), Epworth Sleepiness Scale, T90%, and AHI.
Data were analyzed using SPSS 19.0. Comparisons with P values <0.05 were considered statistically significant.
Additional information on statistical analysis is provided in the online-only Data Supplement.
Results
A total of 8225 individuals, 7107 OSA and 1118 primary snoring patients, were included in the present study. Table S1 in the online-only Data Supplement presents the demographic, clinical, and sleep characteristics of primary snoring and OSA patients. Hypertension was found in 27.3% of those in the primary snoring group versus in 53.8% of OSA patients. Tables 1 and 2 show demographic and clinical characteristics and polysomnography-determined sleep parameters of all patients stratified according to objective and subjective sleep duration, respectively. Patients with shorter objective or subjective sleep duration were older, with lower AHI, higher prevalence of hypertension, and higher systolic BP. The correlation between subjective and objective sleep duration in the entire sample was significant but modest (R=0.125; P<0.001).
As indicated in Table 3 , OSA showed a significant association with hypertension (fully adjusted OR, 1.60; 95% CI, 1.36-1.89; P<0.001). Objective sleep duration was associated with hypertension in a dose-response fashion. As compared to objective sleep duration, 7 to 8 hours (reference), 5 to 6 hours, and <5 hours of sleep increased the odds of hypertension by 39% (OR, 1.39; 95% CI, 1.16-1.66; P<0.001) and by 96% (OR, 1.96; 95% CI, 1.54-2.49; P<0.001), respectively. On the contrary, objective sleep duration >8 hours was associated with decreased odds of hypertension (OR, 0.81; 95% CI, 0.70-0.93; P=0.02). However, no significant relationships were found when subjectively determined sleep duration was considered. Figure 1 illustrates the joint effect of OSA and objective sleep duration on hypertension, reflecting the significant interaction between AHI and objective sleep duration (P=0.016). Compared with primary snoring, OSA with objective sleep duration 5 to 6 hours and <5 hours increased the odds of hypertension by ≈45% (OR, 1.45; 95% CI, 1.14-1.84; P=0.002) and 80% (OR, 1.80; 95% CI, 1.33-2.42; P<0.001), respectively. In contrast, OSA patients with objective sleep duration >8, 7 to 8, Percent for categorical and other variables are presented with mean±SD. AHI indicates apnea-hypopnea index; BMI, body mass index; DBP, diastolic blood pressure; ESS, Epworth Sleepiness Scale; Lowest-Spo 2 , lowest oxygen saturation; OSA, obstructive sleep apnea; REM, rapid eye movement; SBP, systolic blood pressure; TST, total sleep time; and T90%, percentage of sleep time spent below 90% oxygen saturation. and 6 to 7 hours did not have significantly higher likelihood of having hypertension than primary snorers. Figure 2 depicts the frequency of hypertension and BP levels in patients with and without OSA stratified by objective sleep duration. Compared with primary snoring, OSA patients had significantly higher prevalence of hypertension and higher levels of systolic BP and diastolic BP within different sleep duration strata. However, the relationships between sleep time and prevalence of hypertension and BP level were similar within each group of patientshypertension was more frequent, and BP was higher in those exhibiting 5 to 6 or <5 hours of sleep compared with those sleeping 6 to 7, 7 to 8, or >8 hours.
Notably, logistic regression analysis conducted on stratified data showed that compared with primary snoring within the same sleep duration stratum, odds of prevalent hypertension in those with OSA and extremely short sleep (<5 hours; OR, 1.16; 95% CI, 0.67-2.01) were not significant, whereas odds were significant in the other 4 sleep duration strata (5-6, 6-7, 7-8, and >8 hours; Table 4 ).
The associations between different objective sleep duration categories and hypertension risk in subgroups defined according to OSA severity, sex, age, and obesity (body mass index ≥28 kg/m 2 ) 23 are presented in Tables S3 and S4 . The association between hypertension and short objective sleep duration Percent for categorical and other variables are presented with mean±SD. AHI indicates apnea-hypopnea index; BMI, body mass index; DBP, diastolic blood pressure; ESS, Epworth Sleepiness Scale; Lowest-Spo 2 , lowest oxygen saturation; OSA, obstructive sleep apnea; REM, rapid eye movement; SBP, systolic blood pressure; T90%, percentage of sleep time spent below 90% oxygen saturation; and TST, total sleep time.
was present in all levels of OSA severity, both genders, younger ages (<60 years old), and in nonobese patients. We also applied linear regression models to examine the association between sleep duration values and BP within primary snoring and OSA patients, respectively (Tables S5 and S6 ). Objective sleep duration was significantly associated with BP in both primary snorers and OSA patients. Subjective sleep duration was significantly but modestly associated with BP only in OSA patients.
Discussion
We examined the relationship between objective and subjective sleep duration and risk of hypertension in a large population of primary snoring and OSA patients. Our findings suggest that, in patients with OSA, objective short sleep duration, as measured by polysomnography, is associated with hypertension risk in a linear, dose-response manner. Notably, a similar association was not found when subjective sleep duration was used.
The average sleep duration has decreased dramatically during the past decades, from 9 hours in 1910 to 7.5 hours in 1975 and 6.8 hours in 2005. 13 Multiple cross-sectional and longitudinal epidemiological studies have documented a significant relationship between short sleep duration and hypertension. As summarized by 2 recent meta-analyses, decreased sleep duration is associated with 21% increased risk of prevalent hypertension and 23% increased risk of incident hypertension, and the relationship between short sleep and high BP seems to be more pronounced in middle-aged and female subjects. 12, 13, 25 Nevertheless, in the vast majority of these studies, sleep duration was self-reported as only few investigations have evaluated the association between objective sleep duration, as measured by polysomnography, and hypertension.
Little is known about the association of sleep duration with the risk for hypertension in clinical populations of OSA. In a retrospective study of 312 patients who underwent Model 1 was adjusted for age, sex and BMI; model 2 was adjusted for variables included in model 1 and tobacco use, alcohol and coffee consumption, diabetes mellitus, total time in bed, N3 (%TST) and ESS; model 3 was adjusted for variables included in Model 2 and T90% and AHI (or TST). AHI indicates apnea-hypopnea index; BMI, body mass index; CI, confidence interval; ESS, Epworth Sleepiness Scale; OR, odds ratio; OSA, obstructive sleep apnea; T90%, percentage of sleep time spent below 90% oxygen saturation; and TST, total sleep time. Multivariable-adjusted odds ratios and 95% confidence interval for hypertension associated with different categories of objective sleep duration in obstructive sleep apnea (OSA) patients. All data were adjusted for age, sex, body mass index, tobacco, alcohol and coffee consumption, diabetes mellitus, total time in bed, N3 (% total sleep time), Epworth Sleepiness Scale, T90%, and apnea-hypopnea index.*P<0.05. T90% indicates percentage of sleep time spent below 90% oxygen saturation.
polysomnography, Ucar et al 26 found shorter TST in patients with hypertension than in those without hypertension. However, when the analysis was restricted to OSA patients (150 patients), sleep duration <6 hours was not significantly associated with hypertension. Another case-control study found that OSA patients with resistant hypertension had shorter sleep duration than subjects with either controlled hypertension or normotension after controlling for confounders, including OSA severity. 27 Furthermore, Priou et al 21 found a cumulative association between OSA severity and short sleep duration for hypertension because those with OSA and decreased objective sleep duration exhibited the highest risk of hypertension. Our study corroborates these previous findings and further adds to the literature by showing a dose-response relationship between objective sleep duration and risk of hypertension in this population. Furthermore, our data also suggest that normalization of sleep duration should be prioritized specifically in some subsets of OSA patients because subgroup analyses further showed that short objective sleep duration had stronger associations with hypertension, including in patients aged <60 years and nonobese patients. This is further reinforced by our findings on the role of long sleep. Although several studies have found long sleep to be associated with heightened probability of hypertension, 15, 16 the bulk of the evidence points toward a stronger relation with short sleep, as summarized by recent meta-analyses. 13, 25 Our results are in line with the latter observation, as OSA patients sleeping >8 hours exhibited reduced likelihood of having high BP, suggesting that, in this population, prolonged sleep time may be protective against such risk.
Our study failed to find a significant relationship between subjective short sleep duration and hypertension in individuals with OSA, which is in accordance with a prior study in insomnia patients. 28 Objective and self-reported sleep are known to be only moderately correlated. 17, 19 Estimations of sleep duration are often imprecise because of a variety of factors, including fewer years of education, age, lower self-rated health, and work stress, to name a few. 17, 18 In addition, objective and subjective sleep measures may be associated with distinct psychological and biological outcomes. Patel et al 29 found that objective sleep duration was linked to tumor necrosis factor-α, whereas self-reported sleep duration was not. Our results are in line with these concepts, showing a modest relationship between objective and subjective sleep measures and favoring the use of objective sleep measures to determine sleep duration, rather than subjective measures, when attempting to detect comorbidity risk associated with OSA. However, subjective sleep has been identified as a marker for psychological issues, such as depression and anxiety, and for poor perceived health, but no such associations were found with objective sleep measures. 18, 30, 31 The intriguing finding that risk of hypertension in those with OSA and extremely short sleep duration (<5 hours) was comparable to that of primary snorers reporting the same sleep duration suggested that short sleep duration in itself may actually be even more detrimental than OSA, at least in terms of hypertension risk. Improving sleep duration and quality may result in the reduction of both daytime and nighttime BP. 32, 33 The mechanisms underlying the association between sleep duration and hypertension remains unclear although several hypotheses have been proposed. Short sleep duration may increase BP through enhanced sympathetic activity, activation of inflammatory responses, endothelial dysfunction, insulin resistance, and blunted nocturnal BP decreases. [34] [35] [36] [37] Moreover, oxidative stress may be implicated. DeMartino et al 38 found that reduced polysomnography-TST was associated with elevated oxidative stress (myeloperoxidase levels) even after consideration of obesity and OSA severity. They further suggested a differential up-regulation of oxidative stress with objective versus habitual subjective reduced sleep duration, which may also partially explain the different effects of objective and subjective sleep duration on hypertension. In addition, short sleep duration may indirectly contribute to development of hypertension as it is often associated with unhealthy lifestyle habits, 39, 40 such as poor dietary regimens, sedentary living, and smoking, all factors known to predispose to BP elevation.
There are several strengths to this study, including large sample size and that measurements were not confounded by the use of sleep and other psychotropic medication or presence of comorbid sleep and mental disorders. However, many limitations should be addressed. First, our sample consisted predominantly of middle-aged, overweight males; thus, caution should be exercised in extrapolating our results to other populations. Second, as all participants in this study underwent sleep evaluation because of clinical suspicion of OSA, we cannot exclude a selection bias favoring symptomatic OSA, which may limit the generalizability of our findings to asymptomatic patients. Third, objective sleep duration was derived from 1 full-night polysomnography and night to night variability or first night effects cannot be excluded. Actigraphy may constitute a simpler, cost-effective alternative to objectively measure sleep duration for a period of days and thus provide a better representation of habitual sleep duration in the home environment. However, a good level of agreement has been observed between actigraphy and polysomnography for sleep duration measurements in OSA 41 ; Likewise, subjective sleep duration was determined solely in response to a single question during a clinical interview, whereas estimates from 1-to 2-week sleep diary may more comprehensively capture patients' perceived sleep quantity. Fourth, because of the retrospective nature of this study and the population consisting of consecutive referrals to the sleep center because of high pretest probability of OSA, the sample sizes of the OSA and primary snoring groups are unequal. The imbalanced patient cohort may have led to undersampling or oversampling of 1 group and thus to biased prediction models. 42 Finally, BP measurements taken at 2 time points cannot approximate the entire 24-hour BP profile.
Perspectives
In conclusion, our study suggests that objective short sleep duration is independently associated with hypertension in OSA patients. Extremely short objective sleep duration (<5 hours) in itself may actually be even more detrimental than OSA, at least for hypertension risk. Further studies with longitudinal designs are warranted to delineate the temporal association between objective short sleep duration and hypertension and to determine whether interventions to optimize sleep time may also contribute to lower BP in patients with OSA.
